| Compound Information | SONAR Target prediction |
| Name: | 5alpha-ANDROSTAN-3beta,17beta-DIOL |
| Unique Identifier: | SPE00107100 |
| MolClass: | Checkout models in ver1.5 and ver1.0 |
| Molecular Formula: | C19H32O2 |
| Molecular Weight: | 261.21 g/mol |
| X log p: | -0.0960000000000001 (online calculus) |
| Lipinksi Failures | 0 |
| TPSA | 0 |
| Hydrogen Bond Donor Count: | 0 |
| Hydrogen Bond Acceptors Count: | 2 |
| Rotatable Bond Count: | 0 |
| Canonical Smiles: | CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O |
| Source: | testosterone metabolite |
| Reference: | J Org Chem 26: 2043 (1961); J Med Chem 9: 924 (1966) |
| Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL |
| Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL |
| Drug_type: | Experimental |
| Drugbank_id: | EXPT00530 |
| Logp: | 3.73 |
| Drug_category: | Sex Hormone-Binding Globulin inhibitor |
| Organisms_affected: | -1 |